Aimei Health Q2 FY26 net loss widens to $83,144; six-month net loss totals $37,704
AFJK•Merger agreement terminated
The company said it terminated its United Hydrogen merger agreement on July 7, 2026 after CSRC approval had not been granted as of July 6, 2026.
Six-month results and liquidity
For the six months ended June 30, 2026, net loss totaled $37,704, compared with net income of $609,632 a year earlier.
Cash outside the trust account was $1,466, with $12.49 million held in the trust account and a working capital deficit of about $3.79 million.
Quarterly loss widens as interest income declines
Aimei Health posted a net loss of $83,144 for the quarter ended June 30, 2026, versus net income of $424,970 a year earlier.
General and administrative costs rose to $192,348, while interest income from the trust account fell to $109,204.
